News and Updates

Discover stories from Breakthrough T1D about our research, advocacy, initiatives, and supporters.

The latest

Read the latest news from Breakthrough T1D.

20 men in cycling gear and bike helmets, all wearing identical jerseys reading "Ride Pat Ride," pose for a photo with a bike in front of a mural reading "Greetings from Fairport, NY."

On July 15, Pat McAleer flew from Richmond, VA, to Seattle, WA, dipped his bike in the Pacific Ocean at La Push, WA, and embarked on Ride Pat Ride—a solo, 5,000+ mile, three-month journey to the Atlantic Ocean at Virginia Beach, VA, all to raise money for type 1 diabetes (T1D) cures. We last checked […]

Islet cell therapies for type 1 diabetes (T1D) are in the works. In clinical trials, people are coming off external insulin—and experiencing healthy blood sugar levels. Researchers and clinicians are working hard behind the scenes to advance next-generation manufactured islet cell therapies as scalable cures. The momentum is real—and it’s more important than ever to […]

A man, two boys, and a woman holding a girl pose in front of a background reading "Breakthrough T1D."

Breakthrough T1D Walk is a nationwide movement dedicated to raising type 1 diabetes (T1D) awareness and funding research. As the largest T1D walk, this event empowers individuals and teams to take action, and that includes the Burns family of Elysburg, PA. Alyssa Burns says Breakthrough T1D Walk came into her life last year, a few months […]

Older man with type 1 diabetes wears a continuous glucose monitor on his arm while driving

Finerenone is the First Therapy Approved in 30 Years for Kidney Disease and T1D Today, the U.S. Food and Drug Administration (FDA) approved finerenone (brand name Kerendia) to reduce urinary albumin-to-creatinine ratio (UACR) in adults with chronic kidney disease (CKD) associated with type 1 diabetes (T1D). UACR is a measure of kidney damage, and reducing […]

New Publication Alert! Breakthrough T1D spearheaded a paper titled “International consensus guidance for general population screening for islet autoantibodies to diagnose early-stage type 1 diabetes” that was published in Diabetologia. This is an important step toward integrating general population screening for type 1 diabetes (T1D) into clinical practice globally. Read on to learn more about […]

To accomplish our mission of a world without type 1 diabetes (T1D), one thing is clear: the more minds we have thinking about T1D, the better. That’s why Breakthrough T1D brings in interns each year, including in our Research department. Training the next generation isn’t just about career development—it’s about fresh eyes, new ideas, diverse […]

Recent articles

This article was written by Francine Maloney, MPH (Director, Implementation and Director, U.S. Coalition for Early T1D Action) and Umila Singh, MFA (Design Specialist, Innovation) from Ariadne Labs at Brigham and Women’s Hospital and Harvard T.H. Chan School of Public Health. The U.S. Coalition for Early T1D Action has utilized our Participant Advisory Council (PAC) […]

A white man balances on top of a bike covered in bags and panners next to a sign reading "Continental Divide: Elevation 1420 FT."

On July 15, Pat McAleer flew from Richmond, VA, to Seattle, WA, dipped his bike in the Pacific Ocean at La Push, WA, and embarked on Ride Pat Ride—a solo, 5,000+ mile, three-month journey to the Atlantic Ocean at Virginia Beach, VA, all to raise money for type 1 diabetes (T1D) cures. We first checked […]

What’s Happening? The U.S. Food and Drug Administration (FDA) approved Abbott’s Libre Duo 10 Day, the world’s first two-in-one sensor that monitors both glucose and ketones. People with diabetes ages two and up will soon be able to access this technology in the U.S. This follows from its recent approval in Europe earlier this year. […]

IQVIA Finds New Way to Diagnose T1D in Adults

Misdiagnosing adults with type 1 diabetes (T1D) is an all-too-common problem that can have tragic consequences. Breakthrough T1D and IQVIA partnered up to tackle it—and the results were just published.

A spread of school and type 1 diabetes supplies on a table.

Vale Long was diagnosed with type 1 diabetes (T1D) in December 2025, when she was 9 years old. The Wilmington, North Carolina fourth grader says managing her T1D is all about planning ahead. “Every time before I leave the house, I always make sure my pump’s good, I have my glucagon, I have some sugar […]

Breakthrough T1D funded research in cures

A cornerstone of Breakthrough T1D is awarding funding to scientists, researchers, and clinicians who are embarking on promising type 1 diabetes (T1D) research projects. The research we fund spans across the entire spectrum of T1D, including underlying biological and genetic causes, new approaches to cures, advanced technologies, clinical trials, and more. Here, we feature Remi […]

A white man in a red raincoat and white bike helmet smiles while standing next to a bike covered in saddle bags on a beach.

Embarking on a cross-country cycling odyssey requires a lot of planning. For Pat McAleer, the journey began in 2009, when his daughter Mary Kate was diagnosed with type 1 diabetes (T1D) at 10 years old, as she navigated the daily challenges of this condition with incredible strength. “Since then, my wife Molly and I have […]

Breakthrough T1D partners attend the Global Summit to End Diabetes Stigma

The inaugural Global Summit to End Diabetes Stigma aimed to confront and reduce the stigma that impacts the lives of people with diabetes.

Press releases

Read the latest press releases and statements from Breakthrough T1D.

View All

Get the Latest T1D Updates

Sign up for our monthly mission progress newsletter, The Pipeline, to stay up to date on everything you need to know about T1D, from research to advocacy, to clinical care – and everything in between.

  • This field is for validation purposes and should be left unchanged.